Investor Relations

Press Release

November 8, 2023

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2023

More
November 1, 2023

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2023

More
September 13, 2023

Amphastar Pharmaceuticals Announces Pricing of Offering of $300.0 Million of Convertible Senior Notes

More
September 11, 2023

Amphastar Pharmaceuticals Announces Proposed Private Offering of $300.0 Million of Convertible Senior Notes

More
August 31, 2023

Amphastar Pharmaceuticals to Present at the Wells Fargo Healthcare Conference

More
August 8, 2023

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2023

More
August 2, 2023

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2023

More
June 30, 2023

Amphastar Pharmaceuticals Completes Acquisition of BAQSIMI from Lilly

More
May 31, 2023

Amphastar Pharmaceuticals to Present at the Jefferies Healthcare Conference

More
May 9, 2023

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2023

More
Youtube